PMID- 29359846 OWN - NLM STAT- MEDLINE DCOM- 20180917 LR - 20180917 IS - 1399-3062 (Electronic) IS - 1398-2273 (Linking) VI - 20 IP - 2 DP - 2018 Apr TI - Progressive multifocal leukoencephalopathy after T-cell replete HLA-haploidentical transplantation with post-transplantation cyclophosphamide graft-versus-host disease prophylaxis. PG - e12850 LID - 10.1111/tid.12850 [doi] AB - A 52-year-old man suffered from progressive multifocal leukoencephalopathy (PML) after human leukocyte antigen (HLA)-haploidentical transplantation with post-transplantation cyclophosphamide (PTCY). Mirtazapine, mefloquine, and cytarabine failed to improve his symptoms, and he finally died 4.5 months after PML onset. This is the first case report of a patient with PML after HLA-haploidentical transplantation with PTCY. Although T-cell replete HLA-haploidentical transplantation with PTCY has enabled early immune reconstitution, PML should be considered if a patient's mental condition deteriorates. CI - (c) 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. FAU - Ikegawa, Shuntaro AU - Ikegawa S AUID- ORCID: 0000-0002-0337-9867 AD - Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan. FAU - Fujii, Nobuharu AU - Fujii N AD - Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan. FAU - Tadokoro, Koh AU - Tadokoro K AD - Department of Neurology, Okayama University Hospital, Okayama, Japan. FAU - Sato, Kota AU - Sato K AD - Department of Neurology, Okayama University Hospital, Okayama, Japan. FAU - Iwamoto, Miki AU - Iwamoto M AD - Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan. FAU - Matsuda, Masayuki AU - Matsuda M AD - Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan. FAU - Inomata, Tomoko AU - Inomata T AD - Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan. FAU - Sugiura, Hiroyuki AU - Sugiura H AD - Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan. FAU - Asano, Takeru AU - Asano T AD - Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan. FAU - Yoshida, Shohei AU - Yoshida S AD - Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan. FAU - Nishimori, Hisakazu AU - Nishimori H AD - Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan. FAU - Matsuoka, Ken-Ichi AU - Matsuoka KI AD - Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan. FAU - Maeda, Yoshinobu AU - Maeda Y AD - Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan. LA - eng PT - Case Reports PT - Journal Article DEP - 20180301 PL - Denmark TA - Transpl Infect Dis JT - Transplant infectious disease : an official journal of the Transplantation Society JID - 100883688 RN - 0 (HLA Antigens) RN - 0 (Immunosuppressive Agents) RN - 8N3DW7272P (Cyclophosphamide) SB - IM MH - Cyclophosphamide/*therapeutic use MH - Graft vs Host Disease/*prevention & control MH - HLA Antigens/*genetics MH - Humans MH - Immunocompromised Host MH - Immunosuppressive Agents/administration & dosage/adverse effects/therapeutic use MH - Leukoencephalopathy, Progressive Multifocal/*etiology MH - Lymphoma, Follicular/complications MH - Lymphoma, Large B-Cell, Diffuse/therapy MH - Male MH - Middle Aged MH - Stem Cell Transplantation/*adverse effects MH - Transplantation, Haploidentical OTO - NOTNLM OT - haploidentical transplantation OT - post-transplantation cyclophosphamide OT - progressive multifocal leukoencephalopathy EDAT- 2018/01/24 06:00 MHDA- 2018/09/18 06:00 CRDT- 2018/01/24 06:00 PHST- 2017/04/01 00:00 [received] PHST- 2017/07/19 00:00 [revised] PHST- 2017/10/15 00:00 [accepted] PHST- 2018/01/24 06:00 [pubmed] PHST- 2018/09/18 06:00 [medline] PHST- 2018/01/24 06:00 [entrez] AID - 10.1111/tid.12850 [doi] PST - ppublish SO - Transpl Infect Dis. 2018 Apr;20(2):e12850. doi: 10.1111/tid.12850. Epub 2018 Mar 1.